Encompass Health Corporation Restricted Cash, Current
Encompass Health Corporation (EHC) had Restricted Cash, Current of $25.80 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Restricted Cash and Cash Equivalent, Current
us-gaap:RestrictedCashCurrent · last filed 2026-08-07
- 2026-06-30: Restricted Cash, Current $25.80M.
- 2026-03-31: Restricted Cash, Current $52.90M.
- 2025-12-31: Restricted Cash, Current $30.70M.
- 2025-09-30: Restricted Cash, Current $45.00M.
| Period end | Restricted Cash, Current | Restricted Cash, Current as first filed |
|---|---|---|
| 2026-06-30 | $25.80M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $52.90M 10-Q · filed 2026-05-01 | |
| 2025-12-31 | $30.70M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $45.00M 10-Q · filed 2025-10-31 | |
| 2025-06-30 | $38.30M 10-Q · filed 2026-08-07 | |
| 2025-03-31 | $27.00M 10-Q · filed 2026-05-01 | |
| 2024-12-31 | $37.70M 10-Q · filed 2026-08-07 | |
| 2024-09-30 | $51.10M 10-Q · filed 2025-10-31 | |
| 2024-06-30 | $27.70M 10-Q · filed 2025-08-06 | |
| 2024-03-31 | $38.30M 10-Q · filed 2025-05-01 | |
| 2023-12-31 | $35.10M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $41.50M 10-Q · filed 2024-11-01 | |
| 2023-06-30 | $36.50M 10-Q · filed 2024-08-06 | |
| 2023-03-31 | $34.30M 10-Q · filed 2024-05-02 | |
| 2022-12-31 | $31.60M 10-K · filed 2026-02-26 | |
| 2022-09-30 | $44.30M 10-Q · filed 2023-11-01 | |
| 2022-06-30 | $67.40M 10-Q · filed 2023-08-04 | $70.80M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $57.30M 10-Q · filed 2023-05-03 | $61.00M 10-Q · filed 2022-05-03 |
| 2021-12-31 | $62.50M 10-K · filed 2025-02-28 | $65.10M 10-K · filed 2022-02-25 |
| 2021-09-30 | $73.60M 10-Q · filed 2022-11-02 | $75.90M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $65.00M 10-Q · filed 2022-08-04 | |
| 2021-03-31 | $62.20M 10-Q · filed 2022-05-03 | |
| 2020-12-31 | $63.90M 10-K · filed 2024-02-28 | $65.40M 10-K · filed 2021-02-26 |
| 2020-09-30 | $57.20M 10-Q · filed 2021-11-02 | |
| 2020-06-30 | $56.40M 10-Q · filed 2021-08-03 | |
| 2020-03-31 | $56.70M 10-Q · filed 2021-05-04 | |
| 2019-12-31 | $57.40M 10-K · filed 2023-02-27 | |
| 2019-09-30 | $66.80M 10-Q · filed 2020-11-02 | |
| 2019-06-30 | $56.80M 10-Q · filed 2020-07-31 | |
| 2019-03-31 | $59.00M 10-Q · filed 2020-05-11 | |
| 2018-12-31 | $59.00M 10-K · filed 2022-02-25 | |
| 2018-09-30 | $62.10M 10-Q · filed 2019-10-31 | |
| 2018-06-30 | $65.80M 10-Q · filed 2019-07-31 | |
| 2018-03-31 | $69.40M 10-Q · filed 2019-05-01 | |
| 2017-12-31 | $62.40M 10-K · filed 2021-02-26 | |
| 2017-09-30 | $70.80M 10-Q · filed 2018-10-31 | |
| 2017-06-30 | $73.00M 10-Q · filed 2018-08-02 | |
| 2017-03-31 | $65.60M 10-Q · filed 2018-05-02 | |
| 2016-12-31 | $60.90M 10-K · filed 2020-02-27 | |
| 2015-12-31 | $45.90M 10-K · filed 2019-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | United States | $2.084B | 11.76 |